High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

In silico fragment-based drug design

By Konteatis Zenon D  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1047-1065

Informa Healthcare

Access to resources Recommend Favorite

Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design

By Shurtleff Amy C   Nguyen Tam L   Kingery David A   Bavari Sina  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 935-954

Informa Healthcare

Access to resources Recommend Favorite

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite

Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling

By Sung Jong Hwan   Esch Mandy B   Shuler Michael L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1063-1081

Informa Healthcare

Access to resources Recommend Favorite